Alternatives to antibiotics—a pipeline portfolio review

Lloyd G. Czaplewski(University of Kent), John Rex(Princeton University)

The Lancet Infectious Diseases

January 13, 2016

10.1016/s1473-3099(15)00466-1

Cited by 840

Related Papers

Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America

|Clinical Infectious Diseases|2009|3.2k

Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus

|Clinical Infectious Diseases|2002|2.3k

Guidelines for Treatment of Candidiasis

|Clinical Infectious Diseases|2004|1.4k

Practice Guidelines for the Treatment of Candidiasis

|Clinical Infectious Diseases|2000|927

Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections

|Clinical Infectious Diseases|1997|863